Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.

Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R.

Pediatr Infect Dis J. 2008 Aug;27(8):755-7. doi: 10.1097/INF.0b013e31816fc339.

PMID:
18594482
2.

New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).

Johns TL, Hutter GE.

Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Review.

PMID:
20197476
3.

Haemophilus influenzae type b conjugate vaccines - a South African perspective.

Visser A, Hoosen A.

Vaccine. 2012 Sep 7;30 Suppl 3:C52-7. doi: 10.1016/j.vaccine.2012.06.022. Review.

PMID:
22939022
4.

DTaP-IPV-Hep B-Hib vaccine (Hexaxim®) : a review of its use in primary and booster vaccination.

McCormack PL.

Paediatr Drugs. 2013 Feb;15(1):59-70. doi: 10.1007/s40272-013-0007-7. Review.

PMID:
23338932
5.

DTaP-IPV/Hib vaccine (Pentacel).

Dhillon S, Keam SJ.

Paediatr Drugs. 2008;10(6):405-16. doi: 10.2165/0148581-200810060-00008. Review.

PMID:
18998751
6.

Pediatric combined formulation DTaP-IPV/Hib vaccine.

White C, Halperin SA, Scheifele DW.

Expert Rev Vaccines. 2009 Jul;8(7):831-40. doi: 10.1586/erv.09.59. Review.

PMID:
19538110
7.
8.

Assessing efficacy of Haemophilus influenzae type b combination vaccines.

Granoff DM.

Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S278-87. Review.

PMID:
11709760
9.
10.
11.

Non-pertussis components of combination vaccines: problems with potency testing.

Sesardic D, Dawes CS, Mclellan K, Durrani Z, Yost SE, Corbel MJ.

Biologicals. 1999 Jun;27(2):177-81. Review.

PMID:
10600209
12.

Haemophilus influenzae type b vaccination: long-term protection.

Nascimento-Carvalho CM, de Andrade AL.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S109-14. Review.

13.

Combination vaccines in the South African setting.

Visser A, Hoosen A.

Vaccine. 2012 Sep 7;30 Suppl 3:C38-44. doi: 10.1016/j.vaccine.2012.05.001. Review.

PMID:
22939020
14.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
15.

Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years.

Weston WM, Klein NP.

Expert Rev Vaccines. 2008 Nov;7(9):1309-20. doi: 10.1586/14760584.7.9.1309. Review.

PMID:
18980534
16.

The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.

Gessner BD, Adegbola RA.

Vaccine. 2008 Jun 16;26 Suppl 2:B3-8. doi: 10.1016/j.vaccine.2008.04.013. Review.

PMID:
18793604
17.

[Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme].

Boot HJ, Schouls L, Hahné S, Berbers GA, van de Laar M, Kimman TG.

Ned Tijdschr Geneeskd. 2007 Jan 20;151(3):172-6. Review. Dutch.

PMID:
17288341
18.

Haemophilus influenzae type B disease, vaccines, and care of exposed individuals.

Burns IT, Zimmerman RK.

J Fam Pract. 2000 Sep;49(9 Suppl):S7-13; quiz S14. Review.

PMID:
11032188
19.

The challenge of ongoing Haemophilus influenzae type B carriage and transmission in Alaska.

Lucher LA, Singleton R, Parkinson AJ, Butler JC.

Alaska Med. 1999 Jul-Sep;41(3):61-8. Review.

PMID:
10540498
20.

Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines.

Prymula R, Plisek S.

Expert Opin Biol Ther. 2008 Apr;8(4):503-13. doi: 10.1517/14712598.8.4.503 . Review.

PMID:
18352853

Supplemental Content

Support Center